opc 12759 has been researched along with Glaucoma in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "There were no significant differences in fluorescein staining between the untreated and glaucoma eyedrop-treated groups; however, rose bengal staining and the number of inflammatory cells in the conjunctiva significantly increased after glaucoma eyedrop treatment." | 3.85 | Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits. ( Higashide, T; Kawaguchi, C; Kawaguchi, I; Kobayashi, A; Sakurai, K; Sugiyama, K; Takeji, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawaguchi, I | 1 |
| Kobayashi, A | 1 |
| Higashide, T | 1 |
| Takeji, Y | 1 |
| Sakurai, K | 1 |
| Kawaguchi, C | 1 |
| Sugiyama, K | 1 |
1 other study available for opc 12759 and Glaucoma
| Article | Year |
|---|---|
Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.
Topics: Alanine; Animals; Conjunctiva; Corneal Diseases; Female; Fluorescein; Glaucoma; Microscopy, Electron | 2017 |